Table 1 Baseline characteristics of 734 included patients

Median age, yrs (IQR)

85.1

(10.1)

84.3

(9.5)

89.7

(8.7)

< 0.001‡

Female, n (%)

500

(68.1)

418

(69.1)

82

(63.6)

0.222†

Median BMI, kg/m² (IQR)

23.9

(5.2)

24.0

(5.0)

23.3

(5.1)

0.003‡

Comorbidities, n (%)

Dementia

254

(34.6)

182

(30.1)

72

(55.8)

< 0.001†

Chronic renal insufficiency

360

(49.0)

275

(45.5)

85

(65.9)

< 0.001†

Diabetes

188

(25.6)

150

(24.8)

38

(29.5)

0.271†

Cerebrovaskular disease

174

(23.7)

137

(22.6)

37

(28.7)

0.143†

Chronic pulmonary disease

101

(13.8)

78

(12.9)

23

(17.8)

0.139†

Myocardial infarction

52

(7.1)

38

(6.3)

14

(10.9)

0.066†

Antithrombotics, n (%)

No Antithrombotics

533

(72.6)

455

(75.2)

150

(60.5)

0.001†

Vitamin K antagonist

20

(2.7)

16

(2.6)

4

(3.1)

0.751†

DOAC

162

(22.1)

121

(20.0)

41

(31.8)

0.002†

Thrombocyte aggregation inhibitor

8

(1.1)

5

(0.8)

3

(2.3)

0.130†

ASA grade, n (%)

1 to 2

161

(21.9)

154

(25.5)

7

(5.4)

< 0.000†

3 o 4

573

(78.1)

451

(74.5)

122

(94.6)

Median CCI (IQR)

3

(3)

3

(3)

4

(3)

< 0.001‡

Median preop. Hb level, mmol/l (IQR)

7.7

(1.4)

7.8

(1.3)

7.3

(1.7)

0.001‡

Median preop. GFR, ml/min/1.73 m² (IQR)

60.0

(36.0)

62.5

(33.5)

45.0

(34.0)

< 0.001‡

Median preop. INR (IQR)

1.1

(0.2)

1.1

(0.2)

1.2

(0.3)

< 0.001‡